EUVIMEDEUVIMED entdecken
Crossref

A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies

Zhelong Zhang, Hengyan Zhu, Ke Xie, Jiani Lu, Xiaona Chen, Hangxiang Wang

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2024.11.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Zhelong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatmen…. Hauptthemen laut MEDLINE: Camptothecin, Sorafenib, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers, Shandong Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite significant advancements in anticancer nanotherapeutics, the efficient encapsulation of multiple therapeutic modalities within single nanocarriers remains challenging due to the complex requirements of supramolecular self-assembly and/or chemical modification. These intricate synthesis procedures often impede the clinical translation of promising nanomedicines. In this study, we introduce a cost-effective and straightforward self-assembling cytotoxic nanotherapeutic strategy that enables the noncovalent incorporation of water-insoluble anticancer molecular inhibitors with high drug loading. This was achieved through the lipid conjugation of camptothecin, enabling nanoassembly in aqueous solutions devoid of excipients. These nanoassemblies were further developed into nanovehicles capable of encapsulating a high capacity of structurally diverse cargos, including molecularly targeted agents. Notably, nanoassemblies composed of linoleic acid-conjugated camptothecin and sorafenib demonstrated stability and sustained release of their payloads. The combination nanoparticles exhibited synergistic effects and effectively overcame ABCG2-mediated drug resistance in hepatocellular carcinoma (HCC). Systemic administration of these nanotherapeutics led to sustained tumor growth inhibition in various HCC xenograft-bearing mouse models, including a chemically induced orthotopic HCC model. This innovative supramolecular assembly strategy, which allows a single vehicle to deliver multimodal therapies, shows promise in overcoming drug resistance in human HCC and could be adapted for the development of other injectable nanomedicines, warranting further investigation. STATEMENT OF SIGNIFICANCE: This study advances anticancer nanotherapy by developing a simple and cost-effective self-assembling strategy that enables high loading of multiple water-insoluble chemotherapeutics. Using lipid-conjugated camptothecin, we created stable nanoassemblies capable of synergistically delivering diverse molecularly targeted agents. This combinatory platform effectively overcame therapeutic resistance and demonstrated sustained tumor inhibition in hepatocellular carcinoma-bearing mouse models. This new self-assembling cytotoxic nanotherapeutic strategy has potential applications for the development of other injectable nanomedicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CamptothecinSorafenibNanoparticlesAnimalsHumansAntineoplastic AgentsMolecular Targeted TherapyMiceCarcinoma, HepatocellularMice, NudeLiver NeoplasmsHep G2 CellsDrug SynergismMice, Inbred BALB CCell Line, TumorDrug Delivery Systems

Stichwörter der Autor:innen

CamptothecinCombination therapyNanoparticle deliveryProdrugSorafenib

Substanzen

CamptothecinSorafenibAntineoplastic Agents

Autor:innen und Institutionen

  • The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treat…
  • Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China. Electronic address: cxn@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers
  • Shandong Province Natural Science Foundation
  • Zhejiang University
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zhang, Z., Zhu, H., Xie, K., Lu, J., Chen, X., & Wang, H. (2025). A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2024.11.024

Vancouver

Zhang Z, Zhu H, Xie K, Lu J, Chen X, Wang H. A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2024.11.024

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhelong and Zhu, Hengyan and Xie, Ke and Lu, Jiani and Chen, Xiaona and Wang, Hangxiang},
  title = {A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2024.11.024}
}
Kostenlos starten →